Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Routine EHR Data May Help Predict Pancreatic Cancer Risk

A risk model that uses routine clinical data can identify people at high risk of developing pancreatic cancer over the next 3 years.

Can Romiplostim Reduce Chemo Disruptions in GI Cancer?

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Tumor Debulking Fails to Boost Survival in Metastatic CRC

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

Analysis-Pediatricians Win Round 1 in Vaccine Fight, but Damage Has Been Done

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

‘Failure to Thrive’ Now ‘Faltering Weight’ in Pediatrics

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

Tx Delays in CRC More Common in Urban Men, Racial Minorities

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

Todays Updates

Novel Psychedelic Promising on Resistant Depression

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.

EMA OKs Two Treatments for Small Cell Lung Cancer

Both drugs increase overall and progression-free survival.

Todays Updates

Novel Psychedelic Promising on Resistant Depression

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.

EMA OKs Two Treatments for Small Cell Lung Cancer

Both drugs increase overall and progression-free survival.

Latest News

A risk model that uses routine clinical data can identify people at high risk of developing pancreatic cancer over the next 3 years.

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

News All Time

Risankizumab Effective in Crohn's, Real-World Data Show

Risankizumab is effective in inducing clinical and endoscopic remission and is generally well tolerated in patients with Crohn's disease, a real-world study shows.

Rifabutin Regimen Matches Bismuth Regimen in H pylori Rescue

Rifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.

Italian Toddler Too Sick for Second Transplant, Doctors Say

An Italian toddler left clinging to life after receiving a damaged donor heart, is not well enough to undergo a second transplant, ⁠a panel of specialists ruled on Wednesday.

Guinea-Bissau Stops Vaccine Study Funded by Trump Administration

Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis...

Barrett’s Esophagus Guidance Emphasizes Risk Stratification

Emphasis has shifted to high-quality endoscopy based on patient risk stratification.

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

Navigating Autoimmune Overlap in Celiac Disease, With Daniel Mallon, MD Daniel Mallon, MD

Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.

Navigating Opportunities and Obstacles in Gastroparesis, With Ronen Arai, MD Ronen Arai, MD

Arai breaks down key recommendations from the 2025 AGA gastroparesis guidelines and what they mean for the field at large.

Fasting-Mimicking Diet Elicits Clinical, Biochemical Response in Mild Crohn’s Disease

Fasting-Mimicking Diet Elicits Clinical, Biochemical Response in Mild Crohn’s Disease

Obefazimod As An “Exciting” Potential Treatment for Ulcerative Colitis, With Bruce Sands, MD Bruce Sands, MD

Sands explains the potential benefits of obefazimod and reviews findings from ABTECT 1 and ABTECT 2 presented at ACG 2025.

Joshua Wechsler, MD, on dupilumab's sustained efficacy in pediatric patients with EoE Joshua Wechsler, MD, MSCI

Dupilumab maintained histologic and endoscopic improvements across all pediatric age groups with EoE, according to Joshua Wechsler, MD.

Julie Khlevner, MD, AGAF, Reacts to the FDA Approval of Linaclotide for Pediatric IBS-C Julie Khlevner, MD, AGAF

Julie Khlevner, MD, AGAF, highlights that FDA approval of linaclotide provides the first pharmacologic therapy for pediatric IBS-C.

NASPGHAN: Best Practices for Celiac Disease Follow-up with Dale Lee, MD Dale Lee, MD

Dale Lee, MD, told HCPLive that regular monitoring and potential psychosocial support are important to help children with celiac disease maintain a gluten-free diet.

ANTHEM-UC: Icotrokinra Shows Sustained Efficacy in Moderate-to-Severe Ulcerative Colitis, With Vipul Jairath, MBChB, DPhil Vipul Jaraith, MBChB, DPhil

ANTHEM-UC study findings presented at ACG show efficacy, durability and safety of icotrokinra in adults with moderate-to-severe ulcerative colitis.

Rimegepant Linked to Increased Rectal Compliance, Reduced Rectal Sensation in IBS, With Ayah Matar, MD Ayah Matar, MD

Late-breaking ACG 2025 data link rimegepant to increased rectal compliance and reduced rectal sensation in IBS without constipation.

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

Recommended News For You

Year in Review: Multiple Myeloma

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.

Six breast texture patterns linked to higher risk of invasive cancer

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

Kate Middleton and Remission: Oncologists Weigh In

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

Recommended Articles For You

Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy 

Precision Oncology: Tailoring Cancer Treatment for the Individual 

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers 

Interpreting Iron Studies: What Your Blood Results Really Mean  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

2.

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

3.

a brand-new generic therapy for different types of cancer.

4.

Survey shows cancer anxiety has impact well beyond the individual diagnosed

5.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

1.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

2.

The Surprising Role of Magnesium in Digestion, Sleep and Mental Health 

3.

Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025

4.

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer

5.

Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

2.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

4.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot